What we do


We are R&D experts with a unique combination of three proven skills:

 

Our research and project works are presented in some publications:

  • L. Jurado Medina et al (2021) Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study. The Lancet Infectious Diseases, ISSN 1473-3099, https://doi.org/10.1016/S1473-3099(20)30729-5.

 

  • Zrein M. and Chatelain E. (2020) The unmet medical need for Trypanosoma cruzi-infected patients: Monitoring the disease status. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease,Volume 1866, Issue 3,165628, ISSN 0925-4439.

 

  • Lagatie O. et al. (2019) Assessment of multiplex Onchocerca volvulus peptide ELISA in non-endemic tropical regions. Parasites Vectors 12, 570.

 

  • ZreinM. et al. (2018) A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients. PNTD 12(2): e0006226.

 

  • Granjon E. et al. (2016) Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease. PNTD 10(4): e0004596.